RCM
AEON icon

Rivernorth Capital Management’s AEON Biopharma AEON Stock Holding History

Rivernorth Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,367
Closed -$3.4M – 486
2023
Q3 		$3.4M Buy
+4,367
New +$2M 0.18% 115
2023
Q1 		– Sell
-1,944
Closed -$1.41M – 638
2022
Q4 		$1.41M Buy
1,944
+1,388
+250% +$995K 0.06% 278
2022
Q3 		$394K Hold
556
– – 0.02% 495
2022
Q2 		$392K Hold
556
– – 0.02% 483
2022
Q1 		$391K Hold
556
– – 0.01% 495
2021
Q4 		$389K Hold
556
– – 0.02% 426
2021
Q3 		$390K Buy
+556
New +$388K 0.02% 338

Other funds holding AEON

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rivernorth Capital Management's AEON Position: Q4 2023 in Review

Rivernorth Capital Management sold out of AEON Biopharma (AEON) in Q4 2023, closing a stake of 4,367 shares — an estimated $3.4M sold.

Rivernorth Capital Management first reported a position in AEON in Q3 2021 and held it in 7 quarters. The position peaked at $3.4M in Q3 2023. 19 funds tracked by Wall St. Rank hold AEON as of Q4 2023.

  • Rivernorth Capital Management reported no remaining AEON Biopharma position as of Q4 2023 after selling out during the quarter.
  • Rivernorth Capital Management sold 4,367 AEON Biopharma shares in Q4 2023, an estimated $3.4M.
  • Rivernorth Capital Management first reported a position in AEON Biopharma in Q3 2021 and held it in 7 quarters.
  • Rivernorth Capital Management's AEON Biopharma position peaked at $3.4M in Q3 2023.
  • 19 funds tracked by Wall St. Rank held AEON Biopharma as of Q4 2023.

Based on Rivernorth Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.